This reactivation of mitochondrial respiration also enhances the sensitivity of ccRCC cells to cytotoxic treatments, highlighting the therapeutic potential of modulating PGC-1α expression in ccRCC. This evidence concerns the gene PPARGC1A and nonpapillary renal cell carcinoma.